DNA Fragmentation Quantification Assay

For assessment of DNA quality for qPCR and NGS assays.

Learn More

Colorectal Cancer

Mutation detection kits for KRAS, BRAF, NRAS, PIK3CA.

Lung Cancer

Mutation detection kits for EGFR, KRAS, EML4-ALK.

Melanoma

Mutation detection kits for BRAF, NRAS, C-KIT.

GIST

Mutation detection kits for C-KIT, PDGFRA.

Welcome to EntroGen, Inc.

EntroGen is a Los Angeles-based biotechnology company with a primary focus on molecular diagnostics in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR-based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. Through a network of distributors, EntroGen’s footprint reaches every corner of the globe to deliver reliable and innovative tools to researchers and clinicians.

EntroGen releases BRCA Complete™ for targeted BRCA1/BRCA2 sequencing

Los Angeles, California – March 20, 2017 — Today EntroGen, Inc. has launched BRCA Complete™: a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms. BRCA Complete™ is a full solution...